Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-098436

Chief Medical Officer acquired 95,990 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 1 in the form +95,990 265,285 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-05 Grant or award : show line 2 in the form Stock Option (Right to Buy) +143,985 143,985 D
Loading xslF345X05/ownership.xml…